Our vision is to improve the treatment of severe diseases. Working with the medicines of the future we focus on oncology.

Human Health

Human HealthOur main goal is to develop new pharmaceuticals with high versatility were there are wide-spread medical needs.

Further reading »

Animal Health

Animal HealthAnimal Health develops and improves existing medical treatments focusing on oncology.

Further reading »

The Share

Latest News

Publication of change in the total number of shares and votes in Oasmia

March 31 2014
The total number of shares and votes in Oasmia Pharmaceutical AB (publ) amounts to 85 572 330 as of March 31, 2014. The increase in the number of shares is attributable to a privace placement carried out in March 2014, which comprised 3 800 000 shares. The share issue was registered in its entirety with the Swedish Companies Registration Office on March 14, 2014.
Further reading »

Animated presentation of XR-17

March 28 2014
Oasmia has released a short animated presentation of XR-17.
Further reading »

Oasmia receives a new MSEK 40 bank loan

March 25 2014
Oasmia Pharmaceutical AB (publ) announced today that in accordance with its financial plan, the company has received a new MSEK 40 bank loan, with a term from April 1 to August 31, 2014. The loan replaces a previous bank loan which is due on March 31, 2014.
Further reading »